56 related articles for article (PubMed ID: 38438700)
1. Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis.
Kesireddy M; Elsayed L; Shostrom VK; Agarwal P; Asif S; Yellala A; Krishnamurthy J
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791870
[TBL] [Abstract][Full Text] [Related]
2. HR
Torrisi R; Jacobs F; Miggiano C; De Sanctis R; Santoro A
Drugs Context; 2023; 12():. PubMed ID: 36926051
[TBL] [Abstract][Full Text] [Related]
3. Breast surgery for patients with de novo metastatic breast cancer: A meta-analysis of randomized controlled trials.
Ren C; Sun J; Kong L; Wang H
Eur J Surg Oncol; 2024 Jan; 50(1):107308. PubMed ID: 38048724
[TBL] [Abstract][Full Text] [Related]
4. Survival among patients with untreated metastatic breast cancer: "What if I do nothing?".
Plichta JK; Thomas SM; Wang X; McDuff SGR; Kimmick G; Hwang ES
Breast Cancer Res Treat; 2024 Jun; 205(2):333-347. PubMed ID: 38438700
[TBL] [Abstract][Full Text] [Related]
5. Genomic Characterization of
Garrido-Castro AC; Spurr LF; Hughes ME; Li YY; Cherniack AD; Kumari P; Lloyd MR; Bychkovsky B; Barroso-Sousa R; Di Lascio S; Jain E; Files J; Mohammed-Abreu A; Krevalin M; MacKichan C; Barry WT; Guo H; Xia D; Cerami E; Rollins BJ; MacConaill LE; Lindeman NI; Krop IE; Johnson BE; Wagle N; Winer EP; Dillon DA; Lin NU
Clin Cancer Res; 2021 Feb; 27(4):1105-1118. PubMed ID: 33293374
[TBL] [Abstract][Full Text] [Related]
6. Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.
Malmgren JA; Mayer M; Atwood MK; Kaplan HG
Breast Cancer Res Treat; 2018 Jan; 167(2):579-590. PubMed ID: 29039120
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand.
Lao C; Kuper-Hommel M; Elwood M; Campbell I; Edwards M; Lawrenson R
Breast Cancer; 2021 Mar; 28(2):387-397. PubMed ID: 33044617
[TBL] [Abstract][Full Text] [Related]
8. De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis.
Gaillard T; Carton M; Mailliez A; Desmoulins I; Mouret-Reynier MA; Petit T; Leheurteur M; Dieras V; Ferrero JM; Uwer L; Guiu S; Gonçalves A; Levy C; Debled M; Dalenc F; Patsouris A; Bachelot T; Eymard JC; Chevrot M; Conversano A; Robain M; Hequet D
Eur J Cancer; 2021 Oct; 158():181-188. PubMed ID: 34689042
[TBL] [Abstract][Full Text] [Related]
9. Does definitive local therapy have a role in select HER2+ de novo metastatic breast cancer patients treated with dual anti-HER2 blockade?
Rosier L; Wang Y; Lee JH; Daily K
Breast Cancer Res Treat; 2022 Jan; 191(2):375-383. PubMed ID: 34787760
[TBL] [Abstract][Full Text] [Related]
10. Fragmentation of Care and Its Association With Survival and Costs for Patients With Breast Cancer in Colombia.
Gamboa Ó; Buitrago G; Patiño AF; Agudelo NR; Espinel LS; Eslava-Schmalbach J; Guevara Ó; Caycedo R; Junca E; Bonilla C; Sánchez R
JCO Glob Oncol; 2023 May; 9():e2200393. PubMed ID: 37167575
[TBL] [Abstract][Full Text] [Related]
11. Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer.
Plichta JK; Thomas SM; Hayes DF; Chavez-MacGregor M; Allison K; de Los Santos J; Fowler AM; Giuliano AE; Sharma P; Smith BD; van Eycken E; Edge SB; Hortobagyi GN
J Clin Oncol; 2023 May; 41(14):2546-2560. PubMed ID: 36944149
[TBL] [Abstract][Full Text] [Related]
12. Implications of missing data on reported breast cancer mortality.
Plichta JK; Rushing CN; Lewis HC; Rooney MM; Blazer DG; Thomas SM; Hwang ES; Greenup RA
Breast Cancer Res Treat; 2023 Jan; 197(1):177-187. PubMed ID: 36334190
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Statistics, 2022.
Giaquinto AN; Sung H; Miller KD; Kramer JL; Newman LA; Minihan A; Jemal A; Siegel RL
CA Cancer J Clin; 2022 Nov; 72(6):524-541. PubMed ID: 36190501
[TBL] [Abstract][Full Text] [Related]
14. Developments in the Management of Metastatic HER2-Positive Breast Cancer: A Review.
Lebert J; Lilly EJ
Curr Oncol; 2022 Apr; 29(4):2539-2549. PubMed ID: 35448182
[TBL] [Abstract][Full Text] [Related]
15. Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial.
Soran A; Ozmen V; Ozbas S; Karanlik H; Muslumanoglu M; Igci A; Canturk NZ; Utkan Z; Evrensel T; Sezgin E;
J Am Coll Surg; 2021 Dec; 233(6):742-751.e5. PubMed ID: 34530124
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
